Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2012
05/18/2012WO2012062157A1 Pyrano[3,2-d]thiazol derivatives and uses thereof as selective glycosidase inhibitors
05/18/2012WO2012061972A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061971A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061926A1 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
05/18/2012WO2012040651A3 Controlled release formulations of opioids
05/18/2012WO2012038980A3 Fused tricyclic compounds as adenosine receptor antagonist
05/18/2012WO2012027611A3 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
05/18/2012WO2012024397A3 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
05/18/2012WO2012016229A3 Oxytocin treatment to improve memory and modify blood glucose
05/18/2012WO2012012410A3 Kappa opioid receptor agonists
05/18/2012WO2012008782A3 Use of carbon nanotubes for preventing or treating brain disease
05/18/2012WO2012003418A3 Functionally selective ligands of dopamine d2 receptors
05/18/2012WO2011158108A3 Aryl substituted indoles and their use as blockers of sodium channels
05/18/2012WO2011145851A3 Cosmetic composition containing a cypress essential oil complex as an active ingredient for enhancing memory and improving cognitive dysfunction
05/18/2012WO2011142620A3 (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants
05/18/2012CA2817547A1 Sheet and liquid combination systems for dermal drug delivery
05/18/2012CA2817337A1 Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
05/18/2012CA2817290A1 Compounds and methods for treating pain
05/18/2012CA2817071A1 Treatment of addiction and impulse-control disorders using pde7 inhibitors
05/18/2012CA2816974A1 Piperidinone carboxamide indane cgrp receptor antagonists
05/18/2012CA2816609A1 S-t-butyl protected cysteine di-peptide analogs and related compounds
05/18/2012CA2815840A1 Methods and compositions for neural disease immunotherapy
05/18/2012CA2815741A1 Triazole derivatives as ligands for gaba receptors
05/18/2012CA2815179A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012CA2815002A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2814998A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2814996A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2814828A1 Method of treatment for mental disorders
05/18/2012CA2812669A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012CA2812667A1 Triazole derivatives and their use for neurological disorders
05/17/2012US20120124704 Infusion of cannabis
05/17/2012US20120122993 Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-(1r)-, methanesulfonate
05/17/2012US20120122987 Treatment of disorders associated with g protein-coupled receptor 35 (gpr35)
05/17/2012US20120122986 Methods of Treating Fragile X Syndrome
05/17/2012US20120122985 Tranexamic Acid Formulations
05/17/2012US20120122982 Use of pufas to treat nerve damage
05/17/2012US20120122978 Use of Ketogenic Compounds for Treatment of Age-Associated Memory Impairment
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122973 Dry processing of retigabine
05/17/2012US20120122969 Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
05/17/2012US20120122966 Use of organic dyes as analgesic agents
05/17/2012US20120122963 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122958 Transcriptional repression leading to parkinson's disease
05/17/2012US20120122952 4-hydroxybutyric acid analogs
05/17/2012US20120122948 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
05/17/2012US20120122934 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122927 3 or 4-substituted piperidine compounds
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122922 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
05/17/2012US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122916 Screening molecules with anti-prion activity: kits, methods and screened molecules
05/17/2012US20120122914 Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives
05/17/2012US20120122913 Combination of curcuminoids and mtor inhibitors for the treatment of tauopathies
05/17/2012US20120122911 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122903 1-h-quinazoline-2, 4-diones for use in the treatment of neuronal ceroid lipofuscinosis
05/17/2012US20120122900 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122899 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122897 Methods of treating patients suffering from movement disorders
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122890 Potassium Channel Modulators
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122888 Potassium Channel Modulators
05/17/2012US20120122883 New salts
05/17/2012US20120122882 Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122878 Combination products
05/17/2012US20120122874 Combination of a sedative and a neurotransmitter modulator, and methods for treating depression
05/17/2012US20120122871 Oligomer-Containing Substituted Aromatic Triazine Compounds
05/17/2012US20120122862 Arginine derivatives with np-i antagonistic activity
05/17/2012US20120122861 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122853 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122851 Pharmaceutical preparation and delivery system
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122848 (+)-3-hydroxymorphinan derivatives as neuroprotectants
05/17/2012US20120122843 Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122830 Pregnenolone sulfate for the treatment of neurologic disorders
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122825 Use of picoplatin to treat prostate cancer
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122822 Compositions for reducing beta-amyloid-induced neurotoxicity comprising beta-secretase inhibitor
05/17/2012US20120122821 Steroid-containing sustained release intraocular implants and related methods
05/17/2012US20120122813 Composition containing oligosaccharides for the treatment/prevention of infections
05/17/2012US20120122802 Animal protein-free pharmaceutical compositions
05/17/2012US20120122795 Accelerated extension of axons
05/17/2012US20120122794 Compound And Method For Treatment Of Alzheimer's Disease
05/17/2012US20120122793 S-Protected Cysteine Analogs and Related Compounds
05/17/2012US20120122792 S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122781 Peptide ligands of somatostatin receptors
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1833